eyeforpharma Japan

[eyeforpharma Japan @EyeforpharmaJ]

The home of pharma solutions #Tokyo, May22-23. Join 450+ pharma decision makers from #Sales, #Marketing, #Digital, #BusinessDevelopment, #MedicalAffairs, #MarketAccess and #RWE related functions.
https://t.co/C6DzgoMbvV https://t.co/HZbUj1S5Mb

[Reuters Events Pharma @RE_Pharma]

If we all have a story to tell, Ian Talmage of @Bayer has a weighty tome. His experience as a patient and carer has profoundly impacted his life and career. This is his story. https://t.co/Eb9snQpPmZ

[eyeforpharma Japan @EyeforpharmaJ]

https://t.co/wl2a3qwkaG

[Reuters Events Pharma @RE_Pharma]

It is common knowledge that medical affairs has mushroomed over the last couple of years, but has it become a victim of its own success? Its expansion urgently calls for new skills and capabilities. https://t.co/VsoyF11Py3

[Reuters Events Pharma @RE_Pharma]

Imagine a world without pills? Digital therapeutics hint at this future. The market is set to expand as technology creates new health solutions. Here are three successful digital therapeutics you need to know about right now: https://t.co/Kn7he5iY6M

[eyeforpharma Japan @EyeforpharmaJ]

Free White Peter ◆ #AstraZeneca, #Celgene and #NovoNordisk discuss if pharma can become the primary partner for improving Japanese healthcare.
Don’t miss out on this exclusive insight.
Download your free copy of the white paper now >>
https://t.co/pfI5fYWbpy

[eyeforpharma Japan @EyeforpharmaJ]

2018年のeyeforpharmaカンファレンスでのディスカッションの概要をお届けするホワイトペーパーをご提供いたします。アストラゼネカ社、セルジーン社、ノボノルディスク ファーマ社、３社の社長による議論のインサイト:無料ダウンロードはこちらから
https://t.co/tUGt78alGg

[Reuters Events Pharma @RE_Pharma]

What is animating the Chief Medical Officer of @Merck right now? We sat down with Steven Hildemann to discuss pharma's biggest opportunities and challenges. https://t.co/AjMaryc98d

[eyeforpharma Japan @EyeforpharmaJ]

"10年後のMRは、今日のMRとは全く様相が異なっているだろう。" 第一三共社ヨーロッパ・コマーシャル・ヘッドのPatrik Grandits氏、Sunovion社とPfizer社で上級職を務めていたスタラテジック・コマーシャル・リーダーのChris Gish氏との対談をご覧下さい。https://t.co/2C8kjFLeCT

[Reuters Events Pharma @RE_Pharma]

What do marketers dream about when they go to bed at night? If it isn't targeting individual customers and mapping out their journeys, it should be. Marketing automation is making this dream a reality. But where does pharma sit in this cycle of maturity? https://t.co/jAib222Gcm